Haloperidol Decanoate (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Haloperidol Decanoate drug offered from Fresenius Kabi USA, LLC. This Typical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | HALOPERIDOL DECANOATE |
SUBSTANCE NAME: | HALOPERIDOL DECANOATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Typical Antipsychotic [EPC] |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2000-02-16 |
END MARKETING DATE: | 0000-00-00 |
Haloperidol Decanoate HUMAN PRESCRIPTION DRUG Details:
Item Description | Haloperidol Decanoate from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/mL) |
START MARKETING DATE: | 2000-02-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-469_ec202f27-6a8c-4375-9261-d3f4c845ef2b |
PRODUCT NDC: | 63323-469 |
APPLICATION NUMBER: | ANDA074893 |
Other HALOPERIDOL DECANOATE Pharmaceutical Manufacturers / Labelers: